PUBMED FOR HANDHELDS

Journal Abstract Search


694 related items for PubMed ID: 21534945

  • 21. Erroneous prenatal diagnosis of congenital adrenal hyperplasia owing to a duplication of the CYP21A2 gene.
    Lekarev O, Tafuri K, Lane AH, Zhu G, Nakamoto JM, Buller-Burckle AM, Wilson TA, New MI.
    J Perinatol; 2013 Jan; 33(1):76-8. PubMed ID: 23269230
    [Abstract] [Full Text] [Related]

  • 22. Congenital adrenal hyperplasia clinical characteristics and genotype in newborn, childhood and adolescence.
    Pasqualini T, Alonso G, Tomasini R, Galich AM, Buzzalino N, Fernandez C, Minutolo C, Alba L, Dain L.
    Medicina (B Aires); 2007 Jan; 67(3):253-61. PubMed ID: 17628913
    [Abstract] [Full Text] [Related]

  • 23. Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia.
    Votava F, Török D, Kovács J, Möslinger D, Baumgartner-Parzer SM, Sólyom J, Pribilincová Z, Battelino T, Lebl J, Frisch H, Waldhauser F, Middle European Society for Paediatric Endocrinology -- Congenital Adrenal Hyperplasia (MESPE-CAH) Study Group.
    Eur J Endocrinol; 2005 Jun; 152(6):869-74. PubMed ID: 15941926
    [Abstract] [Full Text] [Related]

  • 24. 17-Hydroxyprogesterone in children, adolescents and adults.
    Honour JW.
    Ann Clin Biochem; 2014 Jul; 51(Pt 4):424-40. PubMed ID: 24711560
    [Abstract] [Full Text] [Related]

  • 25. Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia.
    Cavarzere P, Samara-Boustani D, Flechtner I, Dechaux M, Elie C, Tardy V, Morel Y, Polak M.
    Eur J Endocrinol; 2009 Aug; 161(2):285-92. PubMed ID: 19451212
    [Abstract] [Full Text] [Related]

  • 26. [Congenital adrenal hyperplasia due to 21-hydroxylase deficiency--management in adults].
    Ambroziak U, Bednarczuk T, Ginalska-Malinowska M, Małunowicz EM, Grzechocińska B, Kamiński P, Bablok L, Przedlacki J, Bar-Andziak E.
    Endokrynol Pol; 2010 Aug; 61 Suppl 1():7-21. PubMed ID: 22127631
    [Abstract] [Full Text] [Related]

  • 27. No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening.
    Hird BE, Tetlow L, Tobi S, Patel L, Clayton PE.
    Arch Dis Child; 2014 Feb; 99(2):158-64. PubMed ID: 24225272
    [Abstract] [Full Text] [Related]

  • 28. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty.
    Bonfig W, Bechtold S, Schmidt H, Knorr D, Schwarz HP.
    J Clin Endocrinol Metab; 2007 May; 92(5):1635-9. PubMed ID: 17299071
    [Abstract] [Full Text] [Related]

  • 29. Growth patterns in the first three years of life in children with classical congenital adrenal hyperplasia diagnosed by newborn screening and treated with low doses of hydrocortisone.
    Bonfig W, Schmidt H, Schwarz HP.
    Horm Res Paediatr; 2011 May; 75(1):32-7. PubMed ID: 20714115
    [Abstract] [Full Text] [Related]

  • 30. Follow-up of 68 children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: relevance of genotype for management.
    Pinto G, Tardy V, Trivin C, Thalassinos C, Lortat-Jacob S, Nihoul-Fékété C, Morel Y, Brauner R.
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2624-33. PubMed ID: 12788866
    [Abstract] [Full Text] [Related]

  • 31. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Völkl TM, Simm D, Beier C, Dörr HG.
    Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
    [Abstract] [Full Text] [Related]

  • 32. Phenotype and genotype correlation of the microconversion from the CYP21A1P to the CYP21A2 gene in congenital adrenal hyperplasia.
    Torres N, Mello MP, Germano CM, Elias LL, Moreira AC, Castro M.
    Braz J Med Biol Res; 2003 Oct; 36(10):1311-8. PubMed ID: 14502362
    [Abstract] [Full Text] [Related]

  • 33. Genotype-phenotype correlation study and mutational and hormonal analysis in a Chinese cohort with 21-hydroxylase deficiency.
    Xu C, Jia W, Cheng X, Ying H, Chen J, Xu J, Guan Q, Zhou X, Zheng D, Li G, Zhao J.
    Mol Genet Genomic Med; 2019 Jun; 7(6):e671. PubMed ID: 30968594
    [Abstract] [Full Text] [Related]

  • 34. Pseudohypoaldosteronism without nephropathy masking salt-wasting congenital adrenal hyperplasia genetically confirmed.
    Balcells C, Gili T, Pérez J, Corripio R.
    BMJ Case Rep; 2013 Jan 30; 2013():. PubMed ID: 23370958
    [Abstract] [Full Text] [Related]

  • 35. Genetic differences between the salt-wasting, simple virilizing, and nonclassical types of congenital adrenal hyperplasia.
    Höller W, Scholz S, Knorr D, Bidlingmaier F, Keller E, Albert ED.
    J Clin Endocrinol Metab; 1985 Apr 30; 60(4):757-63. PubMed ID: 2982907
    [Abstract] [Full Text] [Related]

  • 36. Sodium Chloride Supplementation Is Not Routinely Performed in the Majority of German and Austrian Infants with Classic Salt-Wasting Congenital Adrenal Hyperplasia and Has No Effect on Linear Growth and Hydrocortisone or Fludrocortisone Dose.
    Bonfig W, Roehl F, Riedl S, Brämswig J, Richter-Unruh A, Fricke-Otto S, Hübner A, Bettendorf M, Schönau E, Dörr H, Holl RW, Mohnike K.
    Horm Res Paediatr; 2018 Apr 30; 89(1):7-12. PubMed ID: 29073619
    [Abstract] [Full Text] [Related]

  • 37. [Virilizing congenital adrenal hyperplasia due to 21-hydroxylase deficiency: early diagnosis and response to 2 treatment schedules].
    Cattani A, Mahaha D, Michaud P, Rodríguez JA, López JM, García H, Foradori A, Velásquez CG.
    Rev Chil Pediatr; 1984 Apr 30; 55(6):374-9. PubMed ID: 6536989
    [No Abstract] [Full Text] [Related]

  • 38. Female preponderance in congenital adrenal hyperplasia due to CYP21 deficiency in England: implications for neonatal screening.
    Nordenström A, Ahmed S, Jones J, Coleman M, Price DA, Clayton PE, Hall CM.
    Horm Res; 2005 Apr 30; 63(1):22-8. PubMed ID: 15627780
    [Abstract] [Full Text] [Related]

  • 39. Congenital adrenal hyperplasia: update on prenatal diagnosis and treatment.
    Carlson AD, Obeid JS, Kanellopoulou N, Wilson RC, New MI.
    J Steroid Biochem Mol Biol; 1999 Apr 30; 69(1-6):19-29. PubMed ID: 10418977
    [Abstract] [Full Text] [Related]

  • 40. Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia.
    Therrell BL, Berenbaum SA, Manter-Kapanke V, Simmank J, Korman K, Prentice L, Gonzalez J, Gunn S.
    Pediatrics; 1998 Apr 30; 101(4 Pt 1):583-90. PubMed ID: 9521938
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 35.